CD13 - Revision history

John at 19:37, 4 July 2023

2023-07-04T19:37:43Z

← Older revision		Revision as of 21:37, 4 July 2023
Line 61:		Line 61:
	{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="8"\|'''~~CD13 expression:~~ mature B cell neoplasms'''		!colspan="8"\|'''Expression in mature B cell neoplasms'''
	\|-		\|- <span style="font-size:70%">
	! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL		! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL
	\|-		\|-<span style="font-size:70%">
	\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%

John at 11:05, 3 July 2023

2023-07-03T11:05:56Z

← Older revision		Revision as of 13:05, 3 July 2023
Line 43:		Line 43:
	\|- <span style="font-size:70%">		\|- <span style="font-size:70%">
	!AML!!CMML !!B ALL !!BL \|\|T ALL !!ETP ALL !!MPAL \|\|Hgn</span>		!AML!!CMML !!B ALL !!BL \|\|T ALL !!ETP ALL !!MPAL \|\|Hgn</span>
	\|-		\|-<span style="font-size:70%">
	\|style="width: 12.5%; background: #004466; color:white"\|80-100%*		\|style="width: 12.5%; background: #004466; color:white"\|80-100%*
	\|style="width: 12.5%; background: #004466; color:white"\|80-100%		\|style="width: 12.5%; background: #004466; color:white"\|80-100%

John at 11:04, 3 July 2023

2023-07-03T11:04:41Z

← Older revision		Revision as of 13:04, 3 July 2023
Line 40:		Line 40:
	{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="8"\|~~<span style="font-size:100%">~~'''Expression in primitive cell types'''</font>		!colspan="8"\|'''Expression in primitive cell types'''</font>
	\|-		\|- <span style="font-size:70%">
	! AML !! CMML !! B ALL !! ~~Burkitt~~ \|\| T ALL !! ETP ALL ~~<'''[[ETP ALL\|I]]'''>~~ !! ~~MPAL <'''[[~~MPAL\|~~I]]'''>~~ \|~~\| Hgns~~ <~~'''[[Hgns\|I]]'''~~>		!AML!!CMML !!B ALL !!BL \|\|T ALL !!ETP ALL !!MPAL \|\|Hgn</span>
	\|-		\|-
	\|style="width: 12.5%; background: #004466; color:white"\|80-100%*		\|style="width: 12.5%; background: #004466; color:white"\|80-100%*

John at 11:14, 28 June 2023

2023-06-28T11:14:16Z

← Older revision		Revision as of 13:14, 28 June 2023
Line 38:		Line 38:


	{\| class=wikitable style="text-align: center; font-size:80%; width: ~~87.5~~%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="7"\|<span style="font-size:100%">'''~~CD13 expression:~~ primitive cell types''' ~~''Click (i) on table for additional information'' </span>~~</font>		!colspan="8"\|<span style="font-size:100%">'''Expression in primitive cell types'''</font>
	\|-		\|-
	! AML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL ('''[[~~Early T Precursor ALL (~~ETP-ALL)\|i]]''') !! MPAL ('''[[~~Mixed Phenotype Acute Leukaemia (~~MPAL)\|i]]) \|\| ~~H.gones (~~'''[[~~Haematogones~~\|i]]''')		! AML !! CMML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL <'''[[ETP ALL\|I]]'''> !! MPAL <'''[[MPAL\|I]]'''> \|\| Hgns <'''[[Hgns\|I]]'''>
	\|-		\|-
	\|style="width: 14.25%; background: #~~006699~~; color:white"\|40-80%		\|style="width: 12.5%; background: #004466; color:white"\|80-100%*
	\|style="width: 14.25%; background:#~~66e0ff~~; color:black"\|5-20%		\|style="width: 12.5%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background:#66e0ff; color:black"\|5-20%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%**
	\|style="width: 14.25%; background: #~~E6FAFF~~; color:black"\|<5%		\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%**
	\|style="width: 14.25%; background: #~~E6FAFF~~; color:~~black~~"\|<5%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%**
			\|style="width: 12.5%; background:#004466; color:white"\|80-100%***
	\|-		\|-
	\|}		\|}

John at 15:35, 30 April 2023

2023-04-30T15:35:37Z

← Older revision		Revision as of 17:35, 30 April 2023
Line 55:		Line 55:


	<span style="font-size:90%">'''Notes:''' The main application is in AML ~~(see notes for expression)~~. Aberrant expression is seen ~~in ALL -~~ particularly in B-lineage, although it may be less likely in Burkitt lymphoma. CD13 is not generally expressed in T-ALL~~, but in the correct context~~ CD13 expression can indicate MPAL or ETP-ALL. ~~CD13 is reported to be expressed by some haematognes (click (i) for additional information)~~		<span style="font-size:90%">'''Notes:''' The main application is in AML. Aberrant expression is seen particularly in B-lineage, although it may be less likely in Burkitt lymphoma. CD13 is not generally expressed in T-ALL. CD13 expression can indicate MPAL or ETP-ALL if other markers suggest this.

John at 15:28, 30 April 2023

2023-04-30T15:28:16Z

← Older revision		Revision as of 17:28, 30 April 2023
Line 81:		Line 81:


	{\| class=wikitable style="text-align: center; font-size:80%; width: 71.4%; height 40px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 62.4%; height 40px;"
	\|-		\|-
	!colspan="7"\|'''CD13 expression: mature T cell neoplasms'''		!colspan="7"\|'''CD13 expression: mature T cell neoplasms'''

John at 15:27, 30 April 2023

2023-04-30T15:27:03Z

← Older revision		Revision as of 17:27, 30 April 2023
Line 38:		Line 38:


	{\| class=wikitable style="text-align: center; font-size:80%; width: ~~100~~%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 87.5%; height 20px;"
	\|-		\|-
	!colspan="7"\|<span style="font-size:100%">'''CD13 expression: primitive cell types''' ''Click (i) on table for additional information'' </span></font>		!colspan="7"\|<span style="font-size:100%">'''CD13 expression: primitive cell types''' ''Click (i) on table for additional information'' </span></font>

John at 15:24, 30 April 2023

2023-04-30T15:24:56Z

← Older revision		Revision as of 17:24, 30 April 2023
Line 64:		Line 64:
	! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL		! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL
	\|-		\|-
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
	\|-		\|-
	\|}		\|}

John at 15:21, 30 April 2023

2023-04-30T15:21:05Z

← Older revision		Revision as of 17:21, 30 April 2023
Line 60:		Line 60:
	{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="7"\|'''CD13 expression: mature B cell neoplasms'''		!colspan="8"\|'''CD13 expression: mature B cell neoplasms'''
	\|-		\|-
	! CLL !! MCL !!FL!! MZL !! HCL !! LPL !! PCL		! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL
	\|-		\|-
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%
Line 68:		Line 68:
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%
			\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%

John at 15:02, 30 April 2023

2023-04-30T15:02:56Z

← Older revision		Revision as of 17:02, 30 April 2023
Line 29:		Line 29:

	<span style="color:navy">'''Other relevant information:'''</span>		<span style="color:navy">'''Other relevant information:'''</span>


	Expression is not restricted to myeloid cells, and CD13 is particularly expressed on small intestinal and renal tubular epithelial cells and synaptic membranes from the CNS.		Expression is not restricted to myeloid cells, and CD13 is particularly expressed on small intestinal and renal tubular epithelial cells and synaptic membranes from the CNS.

← Older revision		Revision as of 13:14, 28 June 2023
Line 38:		Line 38:


	{\| class=wikitable style="text-align: center; font-size:80%; width: ~~87.5~~%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="7"\|<span style="font-size:100%">'''~~CD13 expression:~~ primitive cell types''' ~~''Click (i) on table for additional information'' </span>~~</font>		!colspan="8"\|<span style="font-size:100%">'''Expression in primitive cell types'''</font>
	\|-		\|-
	! AML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL ('''[[~~Early T Precursor ALL (~~ETP-ALL)\|i]]''') !! MPAL ('''[[~~Mixed Phenotype Acute Leukaemia (~~MPAL)\|i]]) \|\| ~~H.gones (~~'''[[~~Haematogones~~\|i]]''')		! AML !! CMML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL <'''[[ETP ALL\|I]]'''> !! MPAL <'''[[MPAL\|I]]'''> \|\| Hgns <'''[[Hgns\|I]]'''>
	\|-		\|-
	\|style="width: 14.25%; background: #~~006699~~; color:white"\|40-80%		\|style="width: 12.5%; background: #004466; color:white"\|80-100%*
	\|style="width: 14.25%; background:#~~66e0ff~~; color:black"\|5-20%		\|style="width: 12.5%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background:#66e0ff; color:black"\|5-20%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%**
	\|style="width: 14.25%; background: #~~E6FAFF~~; color:black"\|<5%		\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%**
	\|style="width: 14.25%; background: #~~E6FAFF~~; color:~~black~~"\|<5%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%**
			\|style="width: 12.5%; background:#004466; color:white"\|80-100%***
	\|-		\|-
	\|}		\|}

← Older revision		Revision as of 17:24, 30 April 2023
Line 64:		Line 64:
	! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL		! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL
	\|-		\|-
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
	\|-		\|-
	\|}		\|}

← Older revision		Revision as of 17:21, 30 April 2023
Line 60:		Line 60:
	{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="7"\|'''CD13 expression: mature B cell neoplasms'''		!colspan="8"\|'''CD13 expression: mature B cell neoplasms'''
	\|-		\|-
	! CLL !! MCL !!FL!! MZL !! HCL !! LPL !! PCL		! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL
	\|-		\|-
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%
Line 68:		Line 68:
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%
	\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style= "width: 14.2%; background: #E6FAFF; color:black"\|<5%
			\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%		\|style="width: 14.2%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%